Dr. Houda Bahig, MD, PhD
Claim this profileCentre Hospitalier de l'Université de Montréal
Area of expertise
Pancreatic Cancer
Houda Bahig, MD, PhD has run 3 trials for Pancreatic Cancer. Some of their research focus areas include:
Head And Neck Cancers
Houda Bahig, MD, PhD has run 3 trials for Head and Neck Cancers. Some of their research focus areas include:
Affiliated Hospitals
Centre Hospitalier De L'Université De Montréal
Centre Hospitalier De L'Université De Montréal (CHUM)
Clinical Trials Houda Bahig, MD, PhD is currently running
MRI-Guided Radiotherapy
for Throat Cancer
This is a phase II randomized trial, where patients with histologically proven squamous cell carcinoma of oropharynx that have primary tumor (T3 - T4) in place, treated with curative intent chemoradiation, will be randomized to systematic mid-treatment MRI-based radiotherapy adaptation vs. standard of care. The primary objective is to compare patient-rated dysphagia (as assessed by the MD Anderson Dysphagia Inventory composite score at 6 months post-treatment in patients undergoing routine mid-treatment MR-guided radiotherapy adaptation vs. in patients receiving the current standard of care.
Recruiting
1 award
Phase 2
SABR Boost + Short-course Radiation
for Oropharyngeal Cancer
This is a randomized clinical trial comparing the outcomes of short-course chemoradiation consisting in stereotactic boost to the gross tumor and de-esclalated chemoradiation to the elective neck in human papilloma associated oropharynx cancer vs. the current standard 7-week course chemoradiation.
Recruiting
2 awards
Phase 3
9 criteria
More about Houda Bahig, MD, PhD
Clinical Trial Related
4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Houda Bahig, MD, PhD has experience with
- Stereotactic Ablative Radiotherapy
- Stereotactic Body Radiotherapy (SBRT)
- Conventional Radiotherapy
- Standard Radiotherapy
- Experimental Radiotherapy
- Virtual Group Speech Pathology Intervention
Breakdown of trials Houda Bahig, MD, PhD has run
Pancreatic Cancer
Head and Neck Cancers
Cancer
Post-extubation Dysphagia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Houda Bahig, MD, PhD specialize in?
Houda Bahig, MD, PhD focuses on Pancreatic Cancer and Head and Neck Cancers. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Houda Bahig, MD, PhD currently recruiting for clinical trials?
Yes, Houda Bahig, MD, PhD is currently recruiting for 5 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Houda Bahig, MD, PhD has studied deeply?
Yes, Houda Bahig, MD, PhD has studied treatments such as Stereotactic Ablative Radiotherapy, Stereotactic Body Radiotherapy (SBRT), Conventional Radiotherapy.
What is the best way to schedule an appointment with Houda Bahig, MD, PhD?
Apply for one of the trials that Houda Bahig, MD, PhD is conducting.
What is the office address of Houda Bahig, MD, PhD?
The office of Houda Bahig, MD, PhD is located at: Centre Hospitalier de l'Université de Montréal, Montréal, Quebec H2x 3E4 Canada. This is the address for their practice at the Centre Hospitalier de l'Université de Montréal.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.